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Original article11C-meta-hydroxyephedrine PET/CT imaging allows
in vivo study of adaptive thermogenesis and
white-to-brown fat conversionCarmelo Quarta 1,4,*, Filippo Lodi 2, Roberta Mazza 1, Ferdinando Giannone 3, Laura Boschi 2, Cristina Nanni 4,
Enzo Nisoli 5, Stefano Boschi 2, Renato Pasquali 1, Stefano Fanti 4, Patricia Iozzo 6, Uberto Pagotto 1ABSTRACTSeveral lines of evidence suggest that novel pharmacological approaches aimed at converting white adipose tissue (WAT) into brown adipose tissue
(BAT) may represent an effective therapeutic strategy for obesity and related disorders. (18)F-ﬂuorodeoxyglucose (18F-FDG) is the only positron
emission tomography (PET) tracer commonly used to study BAT function, and so far no functional tools have been described to investigate in vivo
white-to-brown fat conversion. In this report, we show that the PET tracer 11C-meta-hydroxyephedrine (11C-MHED, a norepinephrine analogue)
is a useful tool to investigate the sympathetic nervous system (SNS) activity in BAT of lean and dietary obese mice. Moreover, we demonstrate that
11C-MHED is a speciﬁc marker of the SNS-mediated thermogenesis in typical BAT depots, and that this tracer can detect in vivo WAT to BAT conversion.
& 2013 Elsevier GmbH.
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Open access under CC BY-NC-ND license.1. INTRODUCTION
The key role played by brown adipose tissue (BAT) in the regulation of energy
balance in mammals has been known for decades [1,2]. A high number of
mitochondria and the presence of the uncoupling protein 1 (UCP-1) give
brown adipocytes the ability to control the metabolic efﬁciency in rodents [3].
Moreover, increasing evidence indicates that stimulation of BAT thermogen-
esis promotes whole body energy dissipation and improves the metabolic
proﬁle in animal models of obesity [4–6]. Therefore, molecules able to
activate BAT thermogenesis may have beneﬁcial effects in obesity and related
disorders. Hybrid PET/CT imaging has recently demonstrated the presence of
metabolically active brown fat in adult humans [7–9]. However, it is unclear
whether the small amount of BAT found in adult individuals can signiﬁcantly
inﬂuence whole body energy metabolism. Therefore, the possibility to
increase BAT amount by promoting white adipose tissue (WAT)-to-brown
fat conversion has become a hot research topic in recent years. Several
investigations have reported that white adipocytes can transdifferentiate into
brown adipocytes when appropriately stimulated [10,11]. Moreover, several
transcription factors and endocrine regulators of brown adipocyte differentia-
tion and function have been identiﬁed [12].
To date, non-invasive tools to detect and measure the degree of
WAT to BAT conversion are lacking, though PET/CT imaging of
(18)F-ﬂuorodeoxyglucose (18F-FDG) has been commonly used to inves-
tigate interscapular BAT metabolism. The sympathetic nervous system
(SNS) is a key regulator of BAT thermogenesis [2] and of brown fat cellhttp://dx.doi.org/10.1016/j.molmet.2013.04.002
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speciﬁc norepinephrine (NE)-related signals in BAT [13,14]. However,
the potential use of PET/CT imaging of SNS activity for the analysis of
BAT thermogenesis has not been fully evaluated.
In this report, we examined whether PET/CT imaging of 11C-meta-
hydroxyephedrine (11C-MHED, a positron emitting NE analogue) may be
a suitable technique to measure in vivo SNS-mediated thermogenesis in
BAT. We analyzed 11C-MHED uptake in the interscapular BAT (iBAT) of
lean and diet-induced obese (DIO) mice during activation or blockade of
SNS-mediated thermogenesis. Moreover, to study whether PET/CT
imaging makes it possible to detect and quantify the metabolic activity
of brown adipose cells that are generated de novo in WAT, we analyzed
11C-MHED and 18F-FDG uptake in WAT of mice chronically treated with a
β3-adrenergic receptor (β3AR) agonist, i.e. an approach known to
promote WAT to BAT conversion.2. RESULTS
2.1. In vivo 11C-MHED bio-distribution in BAT
As shown in Figure 1a, PET/CT imaging allowed a clear detection of
11C-MHED avid areas in the iBAT. With preliminary experiments, we had
found that gas anesthesia administration (sevorane with 1% of oxygen
supplementation) profoundly affects 11C-MHED uptake in BAT (data not
shown). Therefore, to characterize the time-dependent bio-distribution ofciences, University of Bologna, Bologna 40138, Italy 2PET Radiopharmacy, Nuclear Medicine Unit, S.
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Figure 1: Analysis of 11C-MHED bio-distribution in BAT. See also Figure S1. (a) Transverse views of PET (left), CT (middle), and PET/CT fused (right) images showing 11C-MHED uptake in the iBAT
(arrow) of a representative mouse. L: left and R:right. (b) PET/CT analysis of the time-course of 11C-MHED distribution in SNS-denervated (n¼6) or sham-operated (n¼6) iBAT depots of C57BL/6
mice analyzed by several repeated PET/CT scans. **po0.005, ***po0.0005 vs. denervated. Data are expressed as standardized uptake value (SUV), representing radioactive counts per gram
of tissue, divided by injected dose of radioactivity per gram of animal weight. (c) Transverse PET images showing 11C-MHED uptake in the iBAT before and after monolateral resection of the SNS
fibers innervating BAT. (d) PET/CT analysis of 11C-MHED uptake in sham-operated iBAT lobe of mice pre-treated with vehicle (n¼4) or desipramine (n¼7) (10 mg/kg i.p.), 30 min before tracer
injection. ***po0.0005 vs. vehicle. (e) Representative photomicrographs showing TH immunoreactivity (arrows) in a sham-operated and in an SNS-denervated iBAT lobe. Magnification,  40.
Original article11C-MHED, animals were repeatedly imaged at different time points (5,
10, 20, 30, 40, 60 or 80 min) after tracer injection. No anesthesia was
used during the 11C-MHED biodistribution phase preceding each scan.
To analyze the speciﬁcity of the PET signal, a selective surgical
denervation of the SNS ﬁbers innervating the left pad of iBAT was
performed. The right BAT pad was sham-operated and used as an
internal control. As opposed to the sham-operated BAT lobe, PET/CT
imaging did not detect any signiﬁcant signal in the denervated BAT pad
(Figure 1b and c). The accumulation of 11C-MHED reached a plateau at
30 min after injection in the sham-operated pad, in which standardized
uptake values (SUVs) were ∼3–5-fold higher than in the denervated pad,
at all the time points analyzed (Figure 1b).
Acute pre-treatment with the NE reuptake transporter (NET) inhibitor
desipramine induced a signiﬁcant 5-fold reduction in the PET signal in
sham-operated pads (Figure 1d), but did not induce any modiﬁcation in
the denervated depots (Figure S1a). The efﬁciency of the surgical
denervation was veriﬁed by tyrosine hydroxylase (TH) immunostaining.
No immunoreactive ﬁbers could be detected in the denervated BAT
pad, whereas these ﬁbers were abundant in the sham-operated pad154 MOLE(Figure 1e). These results show that that PET/CT imaging of 11C-MHED
can reveal SNS activity in BAT with a high degree of speciﬁcity.
2.2. 11C-MHED is a valid tracer to investigate the SNS-dependent BAT
adaptation
Norepinephrine (NE) was widely demonstrated to mediate BAT thermo-
genic activity and UCP-1 expression in response to environmental
temperature acclimation [15,2]. To verify whether 11C-MHED represents
an efﬁcient tracer to analyze the SNS-mediated BAT activation, its bio-
distribution was studied in animals acclimated at different environmental
temperatures. PET/CT scans showed a higher 11C-MHED uptake in BAT
of animals kept at 21 1C than in animals studied at 26 1C (Figure 2a).
Accordingly, UCP-1 protein levels were higher in BAT of mice analyzed
at 21 1C than in those analyzed at 26 1C (Figure S1b).
NE controls BAT activity, mainly through the stimulation of β3-ARs in
brown adipocytes. Thus, we analyzed the 11C-MHED accumulation in
BAT of mice chronically treated with CL316,243, a selective β3–AR
agonist (1 mg/kg per day, i.p. injected for 4 weeks). As shown in
Figure 2b and Figure S1c, 11C-MHED uptake values and UCP-1 proteinCULAR METABOLISM 2 (2013) 153–160 & 2013 Elsevier GmbH. www.molecularmetabolism.com
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Figure 2: Analysis of 11C-MHED uptake in BAT following experimental activation of SNS. See also Figure S1. (a) Analysis of 11C-MHED uptake in iBAT of mice acclimated either at 21 1C (n¼8)
or 26 1C for 3 months (n¼9). **po0.005 vs. vehicle. (b) Analysis of 11C-MHED uptake in iBAT of animals chronically treated either with vehicle (n¼5) or CL316,243 (n¼6, 1 mg/kg per day,
i.p.) for 4 weeks. **po0.005 vs. vehicle. (c) Analysis of 11C-MHED uptake in sham-operated iBAT lobe of mice (n¼5) by three repeated PET/CT scans (1 week of recovery between the scans)
perfomed after vehicle, CL316,243, or CL316,243þSR59230A acute administration. **po0.005 vs. vehicle *po0.05 vs. CL316,243. CL316,243 (1 mg/kg i.p.) was injected 1 h before
tracer administration. SR59230A (5 mg/kg per os) pre-treatment was performed 1 h before CL316,243 injection. (d) Representative PET image showing 11C-MHED accumulation in sham-
operated and SNS-denervated iBAT lobe (arrows) of a representative mouse treated as in Figure 2c. (e) PET/CT analysis of 11C-MHED uptake in sham-operated iBAT lobe of mice treated with
CL316,243 (1 mg/kg i.p.) and subsequent (30 min later) injection of vehicle (n¼5) or desipramine (n¼5) (10 mg/kg i.p.). Tracer was injected 1 h after CL316,243 administration.
***po0.0005 vs. vehicle. (f) Analysis of 11C-MHED uptake in iBAT of SD (n¼5) and HFD (n¼5) mice by two repeated PET/CT scans, performed following acute (1 h) treatment either with
vehicle or CL316,243 (1 mg/kg i.p.). ***po0.0005 vs. SD vehicle by Bonferroni post test. 2-way ANOVA shows significant interaction between diet type and treatment (po0.05) and accounts
for approximately 11,74% of the total variance with F¼7.958. Diet accounts for approximately 6.20% of the total variance with F¼4203. Treatment accounts for approximately 58.46% of the
total variance with F¼39.63. (g) Analysis of 18F-FDG uptake (SUV) in iBAT of lean SD and HFD mice as in Figure 2 f. ***po0.0005 vs. SD vehicle, *po0.05 vs. HFD vehicle by Bonferroni post
test. 2-way ANOVA shows significant interaction between diet type and treatment (po0.01) and accounts for approximately 6.71% of the total variance with F¼7.78. Diet accounts for
approximately 61.09% of the total variance with F¼70.86. Treatment accounts for approximately 6.51% of the total variance with F¼7.55.levels were higher in the BAT of CL316,243-treated animals, as
compared with vehicle treated mice.
To analyze whether 11C-MHED uptake in BAT is affected by the acute
modulation of SNS-mediated thermogenesis, mice with monolateral BAT
sympathectomy were treated with CL316,243 (1 mg/kg), and scanned
by PET/CT 1 h after injection of the agonist. The acute treatment with
CL316,243 induced a signiﬁcant increase in 11C-MHED uptake in the
sham-operated, but not in the denervated BAT pad. This increased
uptake was blocked by SR59230A, a selective β3-AR antagonist [16], as
administered orally (5 mg/kg) 1 h before CL316,243 (Figure 2c and d),
and was also blocked by desipramine administration (Figure 2e).
No signiﬁcant modiﬁcation in 11C-MHED uptake was observed following
either SR59230A, or CL316,243 plus SR59230A treatment in the
SNS-denervated BAT moiety (Figure S1d). Altogether, these results
suggest that 11C-MHED PET/CT imaging can effectively provideMOLECULAR METABOLISM 2 (2013) 153–160 & 2013 Elsevier GmbH. www.molecularmetabolism.coinformation on both acute and chronic changes in SNS-dependent
BAT thermogenesis.
2.3. Analysis of 11C-MHED uptake in the BAT of diet-induced
obese mice
The effect of DIO on SNS activity in BAT has been investigated with
different experimental approaches, although conclusive results are
lacking [2]. To verify the usefulness of the novel imaging technology
in this context, we performed 11C-MHED PET/CT experiments in mice
fed with a standard chow diet (SD) or with a high-fat diet (HFD, 60% of
calories derived from fat). At the end of the speciﬁc dietary regimen,
mice were PET/CT scanned either after acute (1 h) vehicle or CL316,243
(1 mg/kg) treatment. As shown in Figure 2f, CL316,243 induced a
signiﬁcant increase in the BAT 11C-MHED uptake of SD mice, but not of
HFD-fed mice (Figure 2f).m 155
Original articleTo investigate whether the reduced stimulatory effect of CL316,243 on
11C-MHED uptake in HFD mice was paralleled by a decreased BAT
activity, 18F-FDG PET/CT scans were performed using the same
experimental setting as in Figure 2f. As shown in Figure 2g and
Figure S1d, although no differences could be detected in the 18F-FDG
uptake between the vehicle-treated SD and HFD mice, a lower β3-AR
agonist-induced 18F-FDG uptake was observed in BAT of HFD- than SD-
fed mice. These results suggest that the HFD induces a defective BAT
response to acute β3-AR stimulation.
2.4. In vivo analysis of WAT to BAT conversion by 11C-MHED PET/CT
Previous studies have shown that chronic CL316,243 administration
leads to the appearance of cluster of brown adipocytes within WAT of
rodents [17,18]. To assess the potentiality of PET/CT imaging to capture
WAT to BAT transformation, C57BL6 mice fed with SD diet were
chronically treated with CL316,243 (1 mg/kg daily i.p.) or vehicle, for
4 weeks. 11C-MHED and 18F-FDG uptake in the inguinal subcutaneous
(i.s.) WAT was imaged after 4 weeks of treatment. The same animalsC
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Figure 3: PET/CT imaging of WAT following treatment with a 3-AR agonist. See also Figure S2
showing 11C-MHED and 18F-FDG accumulation in the i.s. WAT (arrows) of a representative mouse
lines indicate the image sections reported in the transverse views. (b) Analysis of 11C-MHED uptake
analyzed by PET/CT imaging after 3 weeks or 4 weeks of CL316,243 administration. ****po0.00
3 and 4 weeks with vehicle were cumulated since they were not statistically different. (c) Analysis of
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156 MOLEwere also ‘ad interim' analyzed after 3 weeks of treatment. At the end of
the scanning sessions, mice were sacriﬁced and WAT to BAT conversion
analyzed ex-vivo in the WAT depots that had been imaged.
As shown in Figure 3a, PET/CT imaging revealed the presence of
11C-MHED dense areas in the i.s. WAT depots of mice treated with
CL316,2434 for 4 weeks. CT scans conﬁrmed that the PET signal was
located in WAT (Figure 3a). Notably, the same 11C-MHED avid areas were
detected by 18F-FDG-PET (Figure 3a). No accumulation of 11C-MHED and
18F-FDG was observed in i.s. WAT depots in mice treated with vehicle
(Figure S2a). Quantitatively, both 11CMHED and 18FFDG uptake rates in
the left i.s. WAT depot were twice as high as in the CL316,243-treated
mice than in the vehicle-treated mice after 3 weeks of drug adminis-
tration (Figure 3b and c). A more pronounced (i.e., 3-fold) increase in the
signal was seen in i.s. WAT after 4 weeks of CL316,243 versus vehicle
treatment (Figure 3b and c). The 11C-MHED SUV values in the bladder of
CL316,243- and vehicle-treated mice were similar (Figure S2b), indicat-
ing that the differences observed in the i.s. WAT could not be accounted
for by the spill-over of radioactivity from the bladder.PET/CT CT
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Finally, the ex vivo analyses conﬁrmed that 4-week CL316,243
treatment was able to convert WAT into a SNS-competent brown fat-
like tissue. First, the UCP-1 and peroxisome-proliferator activated
receptor γ co-activator 1 α (PGC-1α) mRNA and protein (UCP-1) levels
were higher in WAT of mice treated with CL316,243 as compared to
those treated with the vehicle (Figure 4a–c). Second, histological
examinations identiﬁed BAT-like tissue, with clusters of multilocular
adipocytes, in the i.s. WAT after CL316,243 treatment (Figure 4d).
Moreover, CL316,243 increased the TH-positive parenchymal nerve
ﬁbers in i.s. WAT (Figure 4d). Importantly, image analysis of WAT density
by CT scan conﬁrmed the histological and molecular data. In fact, CT
Hounsﬁeld Unit (HU) values in the i.s. WAT regions were signiﬁcantly
higher (i.e., higher density) after 3 weeks of CL316,243 treatment than
in vehicle-treated mice, and a more pronounced increase in i.s. WAT
HUs was observed after 4 weeks of treatment (Figure S2c).
Altogether, our ﬁndings document that PET/CT imaging is an effective
tool for non-invasive study of the SNS activation of BAT, and the white-
to-brown fat cell conversion in i.s. WAT after chronic β3-AR stimulation.3. DISCUSSION
A large body of preclinical evidence indicates that BAT thermogenetic
activity is mainly regulated by the SNS [19,20] speciﬁcally by NE action
on β3-AR receptors expressed on adipocytes surface [2]. The SNS is
also a potent regulator of brown adipocyte proliferation and differentia-
tion in rodents [10].
The present study was aimed at (i) validating the use of 11C-MHED PET/
CT imaging to study SNS function in BAT and (ii) investigating the
efﬁciency of PET/CT imaging to trace the white-to-brown fat conversion
in in vivo experimental settings.
11C-MHED is a positron emitting NE analogue, so far exclusively
employed in the characterization of SNS function in the myocardium
by PET imaging. Because it cannot be easily metabolized, 11C-MHED
accumulates in sympathetic neurons, providing a PET signal that is
proportional to local NE turnover [21]. This tracer has also been shown
(in ex-vivo studies) to speciﬁcally accumulate in BAT [13] and we have
recently reported the ﬁrst example of 11C-MHED PET images of BAT,
detecting an increased 11C-MHED accumulation in brown fat of
genetically modiﬁed mice with a high peripheral SNS tone [22]. In the
present study, we provide the ﬁrst evidence that 11C-MHED PET/CT
imaging represents a novel in vivo approach to study SNS activity in
BAT. Indeed, monolateral SNS denervation unequivocally demonstrated
that 11C-MHED accumulation is speciﬁc for the sympathetic innervation
of BAT. Moreover, 11C-MHED uptake in the BAT was fully dependent on
the activity of the neuronal transporter NET, providing further evidence of
the neuronal nature of the signal detected by PET.
Noteworthy, 11C-MHED accumulation in BAT was proportional to the
local level of SNS-induced BAT activity. In fact, when SNS-induced
thermogenesis in BAT was modiﬁed by exposing the animals to different
environmental temperatures, the expected modiﬁcation in 11C-MHED
uptake was observed. Moreover, in the light of the notion that SNS
dependent thermogenesis is mainly due to NE action on β3ARs
expressed on adipocytes, we also studied 11C-MHED uptake in the
BAT of animals treated with the selective β3AR agonist CL316,243.
We chose not to test the effect of NE infusion directly, because the
competition between the labeled and the unlabeled molecules would
have led to an underestimation of 11C-MHED uptake. The data obtained
with this set of experiments showed that acute or chronic modiﬁcations
in BAT thermogenesis induced by CL316,243, were accompanied by aMOLECULAR METABOLISM 2 (2013) 153–160 & 2013 Elsevier GmbH. www.molecularmetabolism.cospeciﬁc neuronal 11C-MHED accumulation in the tissue. On one hand,
these data indicate that 11C-MHED PET/CT is a promising approach to
quantify acute and chronic modiﬁcations in SNS-mediated thermogen-
esis in BAT. On the other hand, they imply a broader biological
interpretation. Indeed, β3-ARs are mainly, albeit not only, expressed in
brown and white adipocytes [23]. Thus, the increase in 11C-MHED
uptake observed in BAT sympathetic neurons after β3-ARs agonism
suggests that, when activated, brown adipocytes are able to modulate
the activity of the local parenchymal sympathetic nerves located in the
BAT. However, because a limited amount of β3-ARs may be expressed
also in neurons [24] our ﬁndings do not fully rule out that the direct
stimulation of β3-AR in SNS neurons may, at least in part, explain our
results.
Intriguingly, the β3-AR agonist-induced BAT 11C-MHED uptake in DIO
mice was signiﬁcantly lower when compared to that of SD-fed mice.
The defect in SNS activity paralleled the impairment in BAT activation by
CL316,243, as shown by 18F-FDG uptake values in corresponding BAT
regions of obese mice. These data highlight that an impaired SNS-brown
adipocyte cross-talk underlies the reduced thermogenic potential of this
tissue in obesity, and that this defect can be monitored and measured
by PET/CT imaging.
In the light of the data showing that PET/CT imaging of BAT 11C-MHED
accumulation is a valid tool to quantify SNS signaling in typical BAT
depots, we also aimed to demonstrate that PET/CT imaging is able to
visualize and measure the functional activity of newly generated brown
adipose cells in the inguinal subcutaneous WAT. When WAT to BAT
conversion was promoted by the chronic treatment with a β3-AR
agonist, a clear-cut, hyper-intense 11C-MHED and 18F-FDG signal could
be detected and quantiﬁed in WAT. Noteworthy, progressively higher
11C-MHED and 18F-FDG uptake values were observed after 3 weeks and
4 weeks of β3-AR agonist treatment, suggesting that tracers accumula-
tion is proportional to the amount of newly generated brown adipose
cells in WAT. A signiﬁcant amount of 11C-MHED and 18F-FDG uptake
was observed in non-adipose sites located in the visceral cavity, such as
the bladder, the liver and the gastrointestinal tract. This extra adipose
labeling limits the possibility to visualize and analyze the phenomenon of
browning in the visceral adipose tissue. Because of its favorable
anatomical localization, the inguinal subcutaneous WAT is less affected
by the effect of spill-over radioactivity from non adipose sites. These
properties make the inguinal WAT an ideal depot for the analysis of
browning by PET/CT imaging. Future studies will be needed to address
whether de novo generated BAT can be quantiﬁed and visualized by
PET/CT imaging in adipose depots located in the visceral cavity.
To our knowledge, these ﬁndings represent the ﬁrst evidence of the
in vivo detection of white-to-brown fat transdifferentiation by non-
invasive imaging, and support the biological notion that white adipo-
cytes, under appropriate conditions, can give rise to functionally active
(as revealed by the increased 18F-FDG signal) and SNS-competent (as
revealed by the increased 11C-MHED signal) brown adipocytes. More-
over, the parallel time-course of accumulation of 18F-FDG and
11C-MHED in WAT during chronic β3 agonist treatment, suggests that
SNS signaling in adipose tissue is importantly involved in the process of
transformation of WAT into thermogenetically active BAT. These data
support the possibility, as previously suggested by analyzing adipose
tissue of chronically cold-exposed mice [11], which SNS activity could
actively contribute to regulate the plastic nature of adipose tissue.
The regulation of brown adipose cells differentiation and thermogenesis
by the SNS is well established in rodents, but still under debate in
humans. Species speciﬁc differences in the mechanisms underlying
SNS mediated thermogenesis in the BAT may exist between rodents andm 157
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Figure 4: Ex-vivo analysis of WAT-to-BAT conversion. (a) UCP-1 mRNA expression analyzed by qPCR in the i.s. WAT, after 4 weeks of vehicle or CL316,243 administration, in the same animals
shown in Figure 3b and c. **po0.005 vs. vehicle. (b) PGC-1 mRNA expression analyzed by qPCR in the i.s. WAT, as in a. **po0.005 vs. vehicle. (c) Western blot analysis of UCP-1 levels in the
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humans [25]. In a recent report, it was shown that mild cold exposure,
but not intra-muscular ephedrine injection, induces a speciﬁc response
by the SNS to activate BAT and increase energy expenditure in humans
[26]. This study, which highlights the role of SNS activation in the
regulation of human BAT activity, suggests also that speciﬁc mechan-
isms mediated by cold exposure, but not by β3-ARs activation, may be
important for regulation of SNS-mediated thermogenesis in human BAT.
In this context, future PET/CT imaging studies using SNS-related PET
tracers (such as 11C-MHED) and PET molecules tracing substrates
oxidation (such as 18F-FDG or 11C-acetate, as shown in [27]) could
provide key information concerning the relationship between SNS
signaling and thermogenesis in human BAT.
In conclusion, 11C-MHED is a novel and efﬁcient tracer for the in vivo
PET/CT characterization of SNS-dependent BAT activity and white-to-
brown fat conversion. Our ﬁndings have translational value, since the
tracer is already available for use in humans.4. EXPERIMENTAL PROCEDURE
4.1. Materials
Desipramine hydrochloride and CL316,243 were purchased from
Sigma-Aldrich and dissolved in 0.9% saline. Synthesis and quality
control of 11C-MHED were performed as previously described [21].
4.2. Animals
Twelve-week old C57BL/6J male mice were housed under conditions of
controlled temperature (21 1C or 26 1C) for 3 months. During this period,
mice were fed with a standard diet or with a high fat diet (60% of
calories from fat), as previously described [22]. At the end of 3 months,
PET/CT imaging studies were performed. If not otherwise speciﬁed, PET/
CT data refer to experiments performed at 21 1C. All procedures were
approved by the Central Veterinary Service of Bologna University. All
experiments were performed in 4 h-fasted animals.
4.3. Monolateral sympathectomy of BAT
Surgical sympathectomy of the interscapular BAT was performed, as
previously described [22], by cutting the nerve bundles of the left BAT
pad. The right interscapular BAT pad was sham operated and used as
an internal control. The quality of the denervation procedure was veriﬁed
in each animal by tyrosine hydroxylase (TH) immunostaining.
4.4. PET/CT imaging
A PET system (Explore Vista, GE, Milwakee, USA) and a CT system
(microCT eXplore Locus, GE) designed for small animals were used.
Synthesis and quality control of 11C-MHED were performed as previously
described [21].
To examine the 11C-MHED bio-distribution in BAT, mice monolaterally
sympathectomized were repeatedly scanned, each one six times, after
tail vein injection of 11C-MHED (30 MBq in 300 μl of saline). During each
imaging session, animals were analyzed at different time points after
tracer injection. No anesthesia was administered after tracer injection,
i.e. during the phase of 11C-MHED bio-distribution, after which a static
PET scan of 10 min was performed under gas sevorane anesthesia
(1% of oxygen supplementation), followed by a CT scan. SUV values in
BAT images were obtained as previously described [22]. 11C-MHED PET
experiments, when not reported otherwise, refer to animals scanned
30 min after the tracer injection.
18F-FDG PET/CT scans were performed as previously described [22]. For
the analysis of WAT-to-BAT conversion, 18F-FDG was injected 2 h afterMOLECULAR METABOLISM 2 (2013) 153–160 & 2013 Elsevier GmbH. www.molecularmetabolism.cothe end of the 11C-MHED PET/CT scanning sessions, in animals treated
either for 3 or 4 weeks with CL316,243 (1 mg/kg per day, i.p.) or vehicle.
4.5. Real time PCR and immunoblotting
Messenger RNA levels were determined by qPCR analysis, performed by
using the iQ Sybr Green Supermix (BioRad, Hercules, California, USA)
with iCycler (BioRad) instrumentation and software. For immunoblotting,
total tissue lysates were separated by SDS-PAGE, transferred to PVDF
membrane and probed with anti-UCP1 and anti-GAPDH antibodies from
Abcam (Cambridge, UK). For further details see the Supplementary
methods.
4.6. Histology and immunohistochemistry
Tissue specimens underwent standard hematoxylin–eosin staining for
morphological analysis. Sections of formalin ﬁxed, parafﬁn embedded BAT
and WAT were stained and revealed using a rabbit polyclonal anti-TH
antibody and a commercially available avidin–biotin–immunoperoxidase
staining system (Vectastain Elite ABC Kit, Vector Laboratories, USA). For
further details see the Supplementary methods.
4.7. Statistics
Student's t test or analysis of variance (ANOVA) with Bonferroni post-hoc
test were used. The software GraphPad Prism 5.0 was used. p value
less than 0.05 were considered statistically signiﬁcant. Data are
expressed as mean 7SEM.ACKNOWLEDGEMENTS
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